Back

Discontinuation of drug treatment due to side effects after first-time percutaneous coronary intervention: a patient perspective.

9 June 2018 (09:15 - 09:26)
Organised by:
Congress Presentation Part of: Oral abstract session - Doctoral Students Pharmacotherapy ACNAP Premium Access EuroHeartCare 2018

About the speaker

Photo
Doctor Trond Roed Pettersen

Haukeland University Hospital, Bergen (Norway)

7 More presentations in this session

Presentation thumbnail
Symptoms of anxiety and depression after percutaneous coronary intervention with comparison to a reference population
Mrs S. Olsen (Harstad, NO)
Abstract
Presentation thumbnail
Double trouble: Implications for care and self-management interventions when patients experience type 2 diabetes post-acute coronary syndrome - qualitative study of the patient's perspective
Mr M. Tanash (Zarqa, JO)
Abstract
Presentation thumbnail
Readmission and differences in self-reported health and lifestyle factors after heart valve surgery
Miss B. Borregaard (Odense, DK)
Abstract Slides
Presentation thumbnail
Home based cardioversion in the Netherlands
Mr G. Hengstman (Maastricht, NL)
Abstract Slides
Presentation thumbnail
The effectiveness of an avatar-based education application on knowledge and response to heart attack symptoms-A pragmatic randomised trial in patients with acute coronary syndrome
Miss J. Tongpeth (Bedford Park, AU)
Abstract Slides

Access the full session

Session thumbnail
Oral abstract session - Doctoral Students

The Event

Event poster

EuroHeartCare 2018

9 June 2018 09:15 CET

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources